Taizhou Enze Medical Center Group
Taizhou Enze Medical Center Group
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-10-07 | NCT07735182 | |
| Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not stated | 2026-02-03 | NCT07385131 | |
| Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis | Post-ERCP Pancreatitis | Recruiting | Phase 4 | 2025-11-18 | NCT07088757 | |
| Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deep Vein Thrombosis, Embolism and Thrombosis, May-Thurner syndrome, Venous Thrombosis, cardiovascular disorder, peripheral vascular disease, thrombotic disease, vascular disorder, vascular malformation | Recruiting | Not applicable | 2025-09-25 | NCT04694248 | |
| Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction | Acute Myocardial Infarction (AMI); Percutaneous Coronary Intervention (PCI) | Not yet recruiting | Phase 4 | 2025-09-04 | NCT07153744 | |
| Drug-induced Kidney Injury Model | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not stated | 2025-04-22 | NCT06939387 | |
| 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2023-02-21 | NCT04813705 |